In the context of inflammation, osteopontin stands out as a potential key biomarker that warrants further investigation, especially given its association with patients experiencing post-acute sequelae of COVID-19 [30], since long COVID is linked to a heightened coagulable state in the acute hospital stay [31]. The gene discussed is SPP1; the disease is COVID-19.